相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cannabis sativa L. as a Natural Drug Meeting the Criteria of a Multitarget Approach to Treatment
Anna Stasilowicz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Cannabis and its constituents for cancer: History, biogenesis, chemistry and pharmacological activities
Samridhi Lal et al.
PHARMACOLOGICAL RESEARCH (2021)
Biased agonism at the cannabinoid receptors - Evidence from synthetic cannabinoid receptor agonists
Monica Patel et al.
CELLULAR SIGNALLING (2021)
CB1 allosteric modulators and their therapeutic potential in CNS disorders
Catharine A. Mielnik et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2021)
Characteristics and circumstances of synthetic cannabinoid-related death
Shane Darke et al.
CLINICAL TOXICOLOGY (2020)
Synthetic cannabinoid receptor agonists: classification and nomenclature
A. J. Potts et al.
CLINICAL TOXICOLOGY (2020)
Challenges and Opportunities in Preclinical Research of Synthetic Cannabinoids for Pain Therapy
Bogdan Ionel Tamba et al.
MEDICINA-LITHUANIA (2020)
Exposure to the cannabinoid agonist WIN 55, 212-2 in adolescent rats causes sleep alterations that persist until adulthood
Lorena Macias-Triana et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
A Guide to Targeting the Endocannabinoid System in Drug Design
Adam Stasiulewicz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Cannabinoids, Endocannabinoids and Sleep
Andrew J. Kesner et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)
Critical Illness Secondary to Synthetic Cannabinoid Ingestion
Ismini Kourouni et al.
JAMA NETWORK OPEN (2020)
Effects of increment 9-tetrahydrocannabinol on aversive memories and anxiety: a review from human studies
Ana Maria Raymundi et al.
BMC PSYCHIATRY (2020)
Metabolism, CB1 cannabinoid receptor binding and in vivo activity of synthetic cannabinoid 5F-AKB48: Implications for toxicity
Anna Pinson et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2020)
Molecular Pharmacology of Synthetic Cannabinoids: Delineating CB1 Receptor-Mediated Cell Signaling
Kenneth B. Walsh et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Therapeutic potential and safety considerations for the clinical use of synthetic cannabinoids
Dennis J. Sholler et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2020)
Nausea-Induced Conditioned Gaping Reactions in Rats Produced by High-Dose Synthetic Cannabinoid, JWH-018
Marieka V. DeVuono et al.
CANNABIS AND CANNABINOID RESEARCH (2020)
Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis
Guy Hindley et al.
LANCET PSYCHIATRY (2020)
Single and combined effects of plant-derived and synthetic cannabinoids on cognition and cannabinoid-associated withdrawal signs in mice
Alyssa M. Myers et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Severe illness associated with reported use of synthetic cannabinoids: a public health investigation (Mississippi, 2015)
Amelia M. Kasper et al.
CLINICAL TOXICOLOGY (2019)
Effects of the synthetic cannabinoid 5F-AMB on anxiety and recognition memory in mice
Shiho Ito et al.
PSYCHOPHARMACOLOGY (2019)
Evidence for the use of cannabinoids in Parkinson's disease
Carsten Buhmann et al.
JOURNAL OF NEURAL TRANSMISSION (2019)
CLINICAL UPDATE Medicinal use of cannabis based products and cannabinoids
Tom P. Freeman et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
The effects of cannabinoid 1 receptor compounds on memory: a meta-analysis and systematic review across species
Faith Borgan et al.
PSYCHOPHARMACOLOGY (2019)
Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review
Laura Orsolini et al.
MEDICINA-LITHUANIA (2019)
Synthetic marijuana is no more marijuana
Biswa Prakash Nayak et al.
ASIAN JOURNAL OF PSYCHIATRY (2019)
The neuropsychopharmacology of cannabis: A review of human imaging studies
Michael A. P. Bloomfield et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Teens and Spice: A Review of Adolescent Fatalities Associated with Synthetic Cannabinoid Use
Anthea B. Mahesan Paul et al.
JOURNAL OF FORENSIC SCIENCES (2018)
CB1 Receptor Signaling in the Brain: Extracting Specificity from Ubiquity
Arnau Busquets-Garcia et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Delta(9)-Tetrahydrocannabinol
Douglas L. Boggs et al.
NEUROPSYCHOPHARMACOLOGY (2018)
The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain Development
Heidi C. Meyer et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Cannabinoid Receptor Type 1 Agonist ACEA Protects Neurons from Death and Attenuates Endoplasmic Reticulum Stress-Related Apoptotic Pathway Signaling
Talita A. Vrechi et al.
NEUROTOXICITY RESEARCH (2018)
Practical considerations in medical cannabis administration and dosing
Caroline A. MacCallum et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2018)
Medical use of cannabis and cannabinoids containing products - Regulations in Europe and North America
Ran Abuhasira et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2018)
Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System
Shenglong Zou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Excretion of metabolites of the synthetic cannabinoid JWH-018 in urine after controlled inhalation
Stefan W. Toennes et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2018)
Enhanced endocannabinoid tone as a potential target of pharmacotherapy
Marek Toczek et al.
LIFE SCIENCES (2018)
Finding order in chemical chaos - Continuing characterization of synthetic cannabinoid receptor agonists
Julie A. Marusich et al.
NEUROPHARMACOLOGY (2018)
Long lasting effects of chronic WIN55,212-2 treatment on mesostriatal dopaminergic and cannabinoid systems in the rat brain
Panagiotis Perdikaris et al.
NEUROPHARMACOLOGY (2018)
Monoacylglycerol lipase (MAGL) as a promising therapeutic target
Ana Gil-Ordonez et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Pharmacodynamic Effects, Pharmacokinetics, and Metabolism of the Synthetic Cannabinoid AM-2201 in Male Rats
Jeremy Carlier et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)
Psychosis and synthetic cannabinoids
Huiqiong Deng et al.
PSYCHIATRY RESEARCH (2018)
Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA
Maren Hermanns-Clausen et al.
CLINICAL TOXICOLOGY (2018)
Endocannabinoids and related N-acylethanolamines: biological activities and metabolism
Kazuhito Tsuboi et al.
INFLAMMATION AND REGENERATION (2018)
Neurocognition and subjective experience following acute doses of the synthetic cannabinoid JWH-018: a phase 1, placebo-controlled, pilot study
Eef L. Theunissen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Synthetic and Non-synthetic Cannabinoid Drugs and Their Adverse Effects-A Review From Public Health Prospective
Koby Cohen et al.
FRONTIERS IN PUBLIC HEALTH (2018)
Acute effects of synthetic cannabinoids: Update 2015
Juliana Tournebize et al.
SUBSTANCE ABUSE (2017)
Assessing the risk of marijuana use disorder among adolescents and adults who use marijuana
Linda Richter et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2017)
The effects of synthetic cannabinoid UR-144 on the human body-A review of 39 cases
Piotr Adamowicz et al.
FORENSIC SCIENCE INTERNATIONAL (2017)
Pyrolysis of UR-144, a synthetic cannabinoid, augments an affinity to human CB1 receptor and cannabimimetic effects in mice
Asuka Kaizaki-Mitsumoto et al.
JOURNAL OF TOXICOLOGICAL SCIENCES (2017)
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 ameliorate neuroinflammatory responses in chronic cerebral hypoperfusion model by blocking NF-κB pathways
Shao-Hua Su et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2017)
Health Risk Behaviors With Synthetic Cannabinoids Versus Marijuana
Heather B. Clayton et al.
PEDIATRICS (2017)
Synthetic Cannabinoid Use Among High School Seniors
Joseph J. Palamar et al.
PEDIATRICS (2017)
Prevalence and Attitudes Regarding Marijuana Use Among Adolescents Over the Past Decade
Richard Miech et al.
PEDIATRICS (2017)
Peripheral endocannabinoid signaling controls hyperphagia in western diet-induced obesity
Donovan A. Argueta et al.
PHYSIOLOGY & BEHAVIOR (2017)
Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease
Debra A. Kendall et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
Association of State Recreational Marijuana Laws With Adolescent Marijuana Use
Magdalena Cerda et al.
JAMA PEDIATRICS (2017)
Synthetic cannabinoids: A review of the clinical implications of a new drug of choice
Shaina A. Freund et al.
JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS (2017)
Activation of cannabinoid receptor 1 is involved in protection against mitochondrial dysfunction and cerebral ischaemic tolerance induced by isoflurane preconditioning
M. Cai et al.
BRITISH JOURNAL OF ANAESTHESIA (2017)
Nabilone pharmacotherapy for cannabis dependence: A randomized, controlled pilot study
Kevin P. Hill et al.
AMERICAN JOURNAL ON ADDICTIONS (2017)
Neuroprotective Properties of Endocannabinoids N-Arachidonoyl Dopamine and N-Docosahexaenoyl Dopamine Examined in Neuronal Precursors Derived from Human Pluripotent Stem Cells
E. V. Novosadova et al.
BIOCHEMISTRY-MOSCOW (2017)
Synthetic Cannabinoids: Psychopharmacology, Clinical Aspects, Psychotic Onset
Giovanni Martinotti et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2017)
Cannabinoid CB1/CB2 receptor agonists attenuate hyperactivity and body weight loss in a rat model of activity-based anorexia
Maria Scherma et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents
Eric Murillo-Rodriguez et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2017)
N-Arachidonoyl Dopamine: A Novel Endocannabinoid and Endovanilloid with Widespread Physiological and Pharmacological Activities
Urszula Grabiec et al.
CANNABIS AND CANNABINOID RESEARCH (2017)
Comparison of the discriminative stimulus and response rate effects of Δ9-tetrahydrocannabinol and synthetic cannabinoids in female and male rats
Jenny L. Wiley et al.
DRUG AND ALCOHOL DEPENDENCE (2017)
A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment
Robert J. Tait et al.
CLINICAL TOXICOLOGY (2016)
A preliminary evaluation of synthetic cannabinoid use among adolescent cannabis users: Characteristics and treatment outcomes
Claire E. Blevins et al.
ADDICTIVE BEHAVIORS (2016)
Effects of various cannabinoid ligands on choice behaviour in a rat model of gambling
Aliou B. Gueye et al.
BEHAVIOURAL PHARMACOLOGY (2016)
CB-Receptor Agonist HU-210 Mimics the Postconditioning Phenomenon of Isolated Heart
A. S. Gorbunov et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2016)
Inhibition of autophagy and enhancement of endoplasmic reticulum stress increase sensitivity of osteosarcoma Saos-2 cells to cannabinoid receptor agonist WIN55,212-2
Guodong Zhang et al.
CELL BIOCHEMISTRY AND FUNCTION (2016)
Age, period, and cohort effects in synthetic cannabinoid use among US adolescents, 2011-2015
Katherine M. Keyes et al.
DRUG AND ALCOHOL DEPENDENCE (2016)
Cannabinoid receptor 2 (CB2) agonists and antagonists: a patent update
Paula Morales et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2016)
Effects of cannabinoid receptor activation by CP55,940 on normal bladder function and irritation-induced bladder overactivity in non-awake anaesthetised rats
Evangelia Bakali et al.
INTERNATIONAL UROGYNECOLOGY JOURNAL (2016)
Comparing the effects of endogenous and synthetic cannabinoid receptor agonists on survival of gastric cancer cells
A. Ortega et al.
LIFE SCIENCES (2016)
REVEALING THE ROLE OF THE ENDOCANNABINOID SYSTEM MODULATORS, SR141716A, URB597 AND VDM-11, IN SLEEP HOMEOSTASIS
Eric Murillo-Rodriguez et al.
NEUROSCIENCE (2016)
Dose-dependent teratogenicity of the synthetic cannabinoid CP-55,940 in mice
Marcoita T. Gilbert et al.
NEUROTOXICOLOGY AND TERATOLOGY (2016)
Nabilone for the Management of Pain
Corey C. Tsang et al.
PHARMACOTHERAPY (2016)
Cannabinoid receptor agonism suppresses tremor, cognition disturbances and anxiety-like behaviors in a rat model of essential tremor
Hassan Abbassian et al.
PHYSIOLOGY & BEHAVIOR (2016)
The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells
C. Morell et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2016)
Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental colitis is related to inhibition of p38MAPK
Ya-Jing Feng et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Vascular Dysfunction in a Transgenic Model of Alzheimer's Disease: Effects of CB1R and CB2R Cannabinoid Agonists
Jorge Navarro-Dorado et al.
FRONTIERS IN NEUROSCIENCE (2016)
Impact of Cannabis, Cannabinoids, and Endocannabinoids in the Lungs
Caroline Turcotte et al.
FRONTIERS IN PHARMACOLOGY (2016)
Behavioral Characterization of the Effects of Cannabis Smoke and Anandamide in Rats
Adriaan W. Bruijnzeel et al.
PLOS ONE (2016)
Comparisons of Δ9-Tetrahydrocannabinol and Anandamide on a Battery of Cognition-Related Behavior in Nonhuman Primates
Brian D. Kangas et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Synthetic Cannabinoid Use and Descriptive Norms among Collegiate Student-Athletes
Kathleen L. Egan et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2016)
Metabolism of endocannabinoids
Michal Biernacki et al.
POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ (2016)
Synthetic Cannabinoids
Brooke Mills et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2015)
Neuropeptide VF Enhances Cannabinoid Agonist WIN55,212-2-Induced Antinociception in Mice
Zheng-lan Han et al.
ANESTHESIA AND ANALGESIA (2015)
Cannabinoids & Stress: Impact of HU-210 on behavioral tests of anxiety in acutely stressed mice
Renee Kinden et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
Modulation of food consumption and sleep-wake cycle in mice by the neutral CB1 antagonist ABD459
Anushka V. Goonawardena et al.
BEHAVIOURAL PHARMACOLOGY (2015)
Endocannabinoids modulate human blood-brain barrier permeability in vitro
William H. Hind et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Medicinal Chemistry of Cannabinoids
V. Kiran Vemuri et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Cannabinoid WIN55, 212-2 induces cell cycle arrest and inhibits the proliferation and migration of human BEL7402 hepatocellular carcinoma cells
Dacai Xu et al.
MOLECULAR MEDICINE REPORTS (2015)
The Therapeutic Potential of Cannabinoids for Movement Disorders
Benzi Kluger et al.
MOVEMENT DISORDERS (2015)
Effects of URB597 as an inhibitor of fatty acid amide hydrolase on WIN55, 212-2-induced learning and memory deficits in rats
Parisa Hasanein et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2015)
Potentiation of the antitumor activity of adriamycin against osteosarcoma by cannabinoid WIN-55,212-2
Feng Niu et al.
ONCOLOGY LETTERS (2015)
WIN 55,212-2, Agonist of Cannabinoid Receptors, Prevents Amyloid β1-42 Effects on Astrocytes in Primary Culture
Diana Aguirre-Rueda et al.
PLOS ONE (2015)
Parsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNS
N. Murataeva et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications
Marisol S. Castaneto et al.
DRUG AND ALCOHOL DEPENDENCE (2014)
Prenatal exposure to teh CB1 and CB2 cannabinoid receptro agonist WIN 55,212-2 alters migration of early-born glutamatergic neurons and GABAergic interneurons in the rat cerebral cortex
Trinidad M. M. Saez et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Synthetic cannabinoids: Analysis and metabolites
Mahmoud A. ElSohly et al.
LIFE SCIENCES (2014)
PERIPHERAL AND INTRA-DORSOLATERAL STRIATUM INJECTIONS OF THE CANNABINOID RECEPTOR AGONIST WIN 55,212-2 IMPAIR CONSOLIDATION OF STIMULUS-RESPONSE MEMORY
J. Goodman et al.
NEUROSCIENCE (2014)
Endocannabinoid Modulation of Cortical Up-States and NREM Sleep
Matthew J. Pava et al.
PLOS ONE (2014)
Cannabinoid type 1 receptor ligands WIN 55,212-2 and AM 251 alter anxiety-like behaviors of marmoset monkeys in an open-field test
Priscila Cagni et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
In vivo and in vitro metabolism of the synthetic cannabinoid JWH-200
Nik De Brabanter et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2013)
Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors
Maheswari Rajasekaran et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
The Endocannabinoids Anandamide and Virodhamine Modulate the Activity of the Candidate Cannabinoid Receptor GPR55
Haleli Sharir et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2012)
WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway
Gohar Fakhfouri et al.
NEUROPHARMACOLOGY (2012)
Stimulation of accumbens shell cannabinoid CB1 receptors by noladin ether, a putative endocannabinoid, modulates food intake and dietary selection in rats
Rahul R. Deshmukh et al.
PHARMACOLOGICAL RESEARCH (2012)
Phase I Hydroxylated Metabolites of the K2 Synthetic Cannabinoid JWH-018 Retain In Vitro and In Vivo Cannabinoid 1 Receptor Affinity and Activity
Lisa K. Brents et al.
PLOS ONE (2011)
Beyond THC: the new generation of cannabinoid designer drugs
Liana Fattore et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2011)
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
R. G. Pertwee et al.
PHARMACOLOGICAL REVIEWS (2010)
Atypical Responsiveness of the Orphan Receptor GPR55 to Cannabinoid Ligands
Ankur Kapur et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Cannabinoid agonist WIN-55,212-2 partially restores neurogenesis in the aged rat brain
Y. Marchalant et al.
MOLECULAR PSYCHIATRY (2009)
Unique agonist-bound cannabinoid CB1 receptor conformations indicate agonist specificity in signaling
Teodora Georgieva et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Activation of G-proteins in brain by endogenous and exogenous cannabinoids
SR Childers
AAPS JOURNAL (2006)
Recent developments in the medicinal chemistry of cannabimimetic indoles, pyrroles and indenes
JW Huffman et al.
CURRENT MEDICINAL CHEMISTRY (2005)
A comparison of the discriminative stimulus effects of Δ9-tetrahydrocannabinol and O-1812, a potent and metabolically stable anandamide analog, in rats
JL Wiley et al.
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2004)
Synthesis and structure-activity relationships of a series of pyrrole cannabinoid receptor agonists
G Tarzia et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2003)
Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity
MJ Wallace et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
The cannabinoid receptor agonist WIN 55,212-2 regulates glutamate transmission in rat cerebral cortex:: an in vivo and in vitro study
L Ferraro et al.
CEREBRAL CORTEX (2001)
Highly selective CB1 cannabinoid receptor ligands and novel CB1/VR1 vanilloid receptor hybrid ligands
V Di Marzo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB1 and CB2 receptor binding
MM Aung et al.
DRUG AND ALCOHOL DEPENDENCE (2000)
分享论文
